El Cajon, CA, United States of America

Arnt Tonnessen


 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 474(Granted Patents)


Location History:

  • San Diego, CA (US) (2001)
  • El Cajon, CA (US) (2003 - 2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Arnt Tonnessen: Innovator in Gene Therapy

Introduction

Arnt Tonnessen is a notable inventor based in El Cajon, California. He has made significant contributions to the field of gene therapy, particularly through his innovative methods of delivering therapeutic agents. With a total of three patents to his name, Tonnessen's work is paving the way for advancements in medical treatments.

Latest Patents

One of Tonnessen's latest patents is focused on skin and muscle-targeted gene therapy using pulsed electrical fields. This invention describes an in vivo method that utilizes pulsed electric fields to deliver therapeutic agents directly into the cells of the skin and muscle. The therapeutic agents can include naked or formulated nucleic acids, polypeptides, and chemotherapeutic agents. This method aims to provide both local and systemic treatments, showcasing Tonnessen's commitment to improving patient care.

Career Highlights

Throughout his career, Tonnessen has been associated with Genetronics, Inc., a company that specializes in innovative medical technologies. His work at Genetronics has allowed him to explore and develop groundbreaking techniques in gene therapy, contributing to the company's reputation as a leader in the field.

Collaborations

Tonnessen has collaborated with esteemed colleagues such as Gunter A Hofmann and Dietmar P Rabussay. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in gene therapy.

Conclusion

Arnt Tonnessen's contributions to gene therapy through his innovative patents and collaborations highlight his role as a significant figure in the medical field. His work continues to inspire advancements that may lead to improved treatments for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…